This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...
Body mass index (BMI) and waist-to-height ratio (a measurement of unhealthy waist size) represent important obesity treatment targets, associated with a lower risk of obesity-related complications A ...
By now, your news feed, your dinner table conversations, and your doctor’s office have been flooded with chatter about the ...
HealthDay on MSN
American College of Gastroenterology, Oct. 24-29
The annual meeting of the American College of Gastroenterology was held from Oct. 24 to 29 in Phoenix, attracting participants from around the world, including gastroenterology and digestive disease ...
Novo Nordisk to present 11 abstracts at the 76th Annual American Association for Study of Liver Diseases congress: Denmark Friday, October 31, 2025, 15:00 Hrs [IST] Novo Nordisk h ...
Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...
Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...
The company’s total revenue from operations in Q2FY26 increased nearly 9% to ₹14,478.31 crore from ₹13,291.39 crore, ...
Wegovy Zepbound cost-effectiveness report finds both drugs remain valuable at higher prices despite affordability concerns, per ICER analysis.
News Medical on MSN
GLP-1 drugs calm inflammation beyond diabetes and weight loss
This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent ...
Americans are getting slimmer; Gallup says the obesity rate has decreased along with increased use of weight loss drugs such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results